RYZODEG PENFIL

Ryzodeg Penfill is a prefilled insulin pen containing a combination of insulin degludec (70%) and insulin aspart (30%). It is used to treat diabetes mellitus in adults.
Key Features
1. Long-acting and rapid-acting insulin: Provides a basal insulin supply (insulin degludec) and a peak insulin supply (insulin aspart).2. Once-daily dosing: Convenient dosing schedule, with the option to administer the dose at the same time every day.3. Prefilled pen: Easy to use and administer insulin doses.
Benefits
1. Improved glycemic control: Helps regulate blood sugar levels and reduce the risk of hypoglycemia.2. Convenient dosing: Once-daily dosing schedule and prefilled pen make it easy to manage diabetes.3. Reduced risk of hypoglycemia: Insulin degludec has a low risk of hypoglycemia due to its flat and stable action profile.
Dosage
1. Adults: The recommended starting dose is 10-20 units once daily, with the option to adjust the dose based on individual needs.
Side Effects
Common side effects are generally mild and may include:
1. Hypoglycemia2. Injection site reactions3. Allergic reactions4. Weight gain5. Nausea6. Diarrhea
Precautions
1. Consult a healthcare professional before using Ryzodeg Penfill, especially if you have a history of kidney or liver disease, or are taking medications.2. Monitor blood sugar levels regularly while taking this medication.3. Rotate injection sites to reduce the risk of injection site reactions.4. Do not mix with other insulins.
Storage and Handling
1. Store Ryzodeg Penfill at room temperature (15°C to 30°C / 59°F to 86°F).2. Protect from light and moisture.3. Use within the expiration date printed on the packaging.